Ezaki K
Department of Internal Medicine, School of Medicine, Fujita-Gakuen Health University.
Hum Cell. 1988 Mar;1(1):60-4.
Low density fractions of Percoll density gradient centrifugation of peripheral mononuclear cells contained the majority of large granular lymphocytes (LGL). LGL were used for 5-hr 51Cr release cytotoxic assay against autologous tumor cells in 20 patients with hematological malignancies (9AML, 4ALL and 7NHL). Mean % cytotoxicity (% CTX) was 6.0%, and the addition of IFN-beta and IL-2 in the medium induced the significant increase of % CTX to 15.0% and 26.1%, respectively. When LGL cultured in medium containing IFN-beta and IL-2 were assessed for cytotoxicity daily for 8 days, the enhancement of % CTX by IFN-beta was declined in a few days, while the enhancement by IL-2 was sustained for more than 8 days. The pretreatment of LGL with anti Leu-11 (CD16) plus complement abrogated the enhancing effect by IFN-beta or IL-2, but not with anti Leu-1 (CD5) plus complement. When this treatment was done on day 8 of IL-2 cocultivation, anti Leu-11 plus complement suppressed cytotoxicity significantly, and anti Leu-1 plus complement also induced mild suppression. The phenotypic characteristics of cells revealed the significant increase of anti Leu-19+ cells in IL-2 stimulated day 8 cells. High density fractions of Percoll gradient contained mostly T lymphocytes and showed no cytotoxicity against autologous tumor cells. However, cocultivation with IL-2 for 8 days induced the cytotoxicity, associated with increased number of anti Leu-19+ cells. These results suggested that IL-2 induced cytotoxic activity against autologous tumor cells might be related to the increase of anti Leu-19+ cells.
外周血单个核细胞经Percoll密度梯度离心后的低密度组分中含有大多数大颗粒淋巴细胞(LGL)。LGL被用于对20例血液系统恶性肿瘤患者(9例急性髓系白血病、4例急性淋巴细胞白血病和7例非霍奇金淋巴瘤)的自体肿瘤细胞进行5小时的51Cr释放细胞毒性测定。平均细胞毒性百分比(% CTX)为6.0%,培养基中添加干扰素-β(IFN-β)和白细胞介素-2(IL-2)后,% CTX分别显著增加至15.0%和26.1%。当对在含有IFN-β和IL-2的培养基中培养的LGL进行为期8天的每日细胞毒性评估时,IFN-β对% CTX的增强作用在数天内下降,而IL-2的增强作用持续超过8天。用抗Leu-11(CD16)加补体预处理LGL可消除IFN-β或IL-2的增强作用,但抗Leu-1(CD5)加补体则不能。当在IL-2共培养的第8天进行这种处理时,抗Leu-11加补体显著抑制细胞毒性,抗Leu-1加补体也诱导轻度抑制。细胞的表型特征显示,在IL-2刺激的第8天细胞中,抗Leu-19+细胞显著增加。Percoll梯度的高密度组分主要含有T淋巴细胞,对自体肿瘤细胞无细胞毒性。然而,与IL-2共培养8天可诱导细胞毒性,同时抗Leu-19+细胞数量增加。这些结果表明,IL-2诱导的针对自体肿瘤细胞的细胞毒性活性可能与抗Leu-19+细胞的增加有关。